Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine ... The FDA approval was awarded to Mylan, which is now part of Viatris after merging with Pfizer's ...
Eli Lilly and Boehringer Ingelheim will undercut Sanofi by 15% with Basaglar, a biosimilar version of the insulin blockbuster Lantus launched today in the US. Basaglar will also undercut Sanofi ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback